Exposure-safety analyses of talazoparib in combination of enzalutamide in patients with metastatic castrationresistant prostate cancer (mCRPC) in TALAPRO-2 trial-MedSci.cn

Exposure-safety analyses of talazoparib in combination of enzalutamide in patients with metastatic castrationresistant prostate cancer (mCRPC) in TALAPRO-2 trial

Azad, AA; Wang, Y; Hadigol, M; Hoffman, J; Agarwal, N; Matsubara, N; Lincha, VR; Zohren, F; DeAnnuntis, L; Wang, D

ANNALS OF ONCOLOGY, 2023; 34 (): S990

科室
- - 订阅+
  - 更多科室
工具
服务